Other Cancers of the Lymphatic System
Hodgkin's Disease and Non-Hodgkin's Lymphoma make up the vast majority of cancers of the lymphatic system. Most other cancers have metastasized from other parts of the body - common metastasized cancers include breast cancer and
other cancers in organs. Below are other lymphatic cancers or conditions that can become malignant (cancerous) that do not fall into the above groups.
Lymphomatoid Papulosis (Reclassified by WHO)
UPDATED: A comprehensive page on LyP by Nikki - see this first
Lymphomatoid Papulosis is now recognized as a skin disorder that can progress into Hodgkin's Disease or forms of Non-Hodgkin's Lymphoma. The prevalence rate is estimated at 1.2 to 1.9 cases per million population. It does not appear to be familial.
If you know of other cancers of the lymphatic system please
write and they may be included here.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
